Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
22 Feb 2022 |
On buy-back programmes |
ROVI reports the end of the share buy-back programme, effective as of 3 November 2021, and the launching of a new share buy-back programme, effective as of 23 February 2022.
|
Download |
|
16 Feb 2022 |
On business and financial situation |
Moderna and ROVI announced that they expand their long-term collaboration for the manufacture of mRNA medicines over the next ten years
|
Download |
|
03 Nov 2021 |
On buy-back programmes |
The Company reports the commencement, effective as of today, 3 November 2021, of a share buyback program.
|
Download |
|
16 Jul 2021 |
On Corporate Governance |
ROVI announces the appointment of Juan López-Belmonte Encina as Chairman of the Company
|
Download |
|
22 Jun 2021 |
On significant placements in financial instruments |
Bestinver announces the beginning of an accelerated book build process of up to a 3% of the share capital of Laboratorios Rovi, S.A.
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
24 Nov 2020 |
On business and financial situation |
The Company releases the presentation related to its strategy update because of the 2020 Capital Markets Day.
|
Download |
|
13 Nov 2020 |
Other relevant information |
The Company informs about the dividends payment
|
Download |
|
05 Nov 2020 |
On business and financial situation |
The company releases the press release related to the 2020 first nine months financial results
|
Download |
|
20 Oct 2020 |
Announcement of general shareholders’ meeting |
ROVI releases the information related to its General Shareholders Meeting
|
Download |
|
15 Oct 2020 |
Announcement of general shareholders’ meeting |
In view of the exceptional circumstances derived from the spread of Covid-19, the Company has agreed that the Ordinary General Meeting be held by exclusively telematic means.
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
26 Feb 2019 |
Información sobre resultados |
ROVI releases the presentation related to the full year 2018 results
|
Download |
|
26 Feb 2019 |
Información sobre resultados |
ROVI releases the press release related to the full year 2018 results
|
Download |
|
15 Feb 2019 |
Others on business performance and financial information |
ROVI acquires rights to Dexchlorpheniramine Maleate in the Spanish and French markets
|
Download |
|
09 Jan 2019 |
Others on business performance and financial information |
ROVI informs about the adquisition of Falithrom® for the German market
|
Download |
|
08 Jan 2019 |
Liquidity contracts and specialists |
Liquidity contract: transactions conducted in the fourth quarter of 2018
|
Download |
Pages
